Axsome Therapeutics Inc.
AXSM | NASDAQ
$136.01
-$8.42 (-5.83%)
At close: Nov 2, 2026, 4:00 PM ET
$137.00
-$7.43 (-5.14%)
Pre-market:
Nov 2, 2026, 9:28 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -51.31M | -64.54M | -28.56M | -47.23M | -47.97M | -59.41M | -74.91M | -64.6M | -79.35M | -68.36M | -98.65M | -62.2M | -67.17M | -11.22M | -61.24M | -44.82M | -41.44M | -39.63M | -33.98M | -34.88M | -32.28M | -29.26M |
Depreciation & Amortization | 1.05M | 2.37M | 2.27M | 2.41M | 1.71M | 1.72M | 2.07M | 2.06M | 1.99M | 1.83M | 1.74M | 1.74M | 1.38M | 1.98M | 2.02M | 1.96M | 1.27M | 311.7K | 307.41K | 299.74K | 277.42K | 271.09K |
Stock-Based Compensation | 27.15M | 23.44M | 22.73M | 23.1M | 24.61M | 23.31M | 21.99M | 21.66M | 21.38M | 20.19M | 18.92M | 14.84M | 15.92M | 12.94M | 10.77M | 9.2M | 10.16M | 7.6M | 5.89M | 5.73M | 5.46M | 3.73M |
Other Working Capital | 48.82M | 7.36M | 13.31M | 48.86M | 18.91M | -4.17M | 27.1M | -16.52M | 33.55M | -13.2M | 13.14M | 13.1M | 3.25M | 4.72M | 12.87M | 22.52M | 6.18M | -384.82K | -793.98K | 316.84K | 4.24M | -3.08M |
Other Non-Cash Items | 1.36M | 985K | -8.27M | 13.98M | 3.56M | 1.16M | 11.85M | 38.32M | 2.98M | -324K | 44.83M | 1.03M | 7.14M | 105K | 4.19M | 119.57K | -658.25K | 8.34K | -34.29K | 522 | -71.09K | 255 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -617K | n/a | 617K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -11.2M | 17.05M | -6.83M | 8.78M | -14.33M | -10.15M | 12.8M | -16.07M | 22.88M | -6.81M | 3.43M | -8.96M | -13.23M | -9.63M | 16.7M | 10.78M | -2.87M | -939.03K | -1.03M | 2.08M | 1.23M | -1.96M |
Operating Cash Flow | -32.95M | -20.7M | -18.65M | 1.05M | -32.42M | -43.38M | -26.2M | -18.63M | -30.11M | -53.47M | -30.36M | -53.55M | -55.35M | -5.82M | -27.56M | -22.76M | -33.54M | -32.65M | -28.84M | -26.78M | -25.39M | -27.22M |
Capital Expenditures | 121K | -121K | -71K | -58K | -13K | -338K | -30K | 150K | -52K | -98K | -7K | -371K | -133K | -71K | -180.86K | -66.06K | -241.46K | -213.74K | 307.55K | -258.68K | -18.88K | -30K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -53M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -571K | n/a | n/a | n/a | n/a | n/a | n/a | -240K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -307.55B | n/a | n/a | n/a |
Investing Cash Flow | -450K | -121K | -71K | -58K | -13K | -338K | -30K | -90K | -52K | -98K | -7K | -371K | -133K | -71K | -180.86K | -66.06K | -53.24M | -213.74K | -307.55B | -258.68K | -18.88K | -30K |
Debt Repayment | -1.21M | -672K | -541K | -664K | -6.14M | -401K | -330K | -311K | -186K | -163K | 855K | -856K | 30M | 53.78M | n/a | n/a | 45M | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.88M | -12.56M | -3.99M | -3.35M | -3.09M | 10.02M | -1.85M | 17.62M | -3.22M | -3.53M | -2M | 476K | -8.92M | -2.61M | -1.76M | -1.1M | -2.09M | -88.59K | -401.04K | n/a | 874.89K | 1.91M |
Financial Cash Flow | 48.15M | 2.99M | 16.39M | 21.27M | 34.54M | 29.27M | 14.24M | 30.41M | 14.38M | -1.19M | -2K | 33.37M | 246.08M | 51.57M | 1.07M | 176.95M | 75.46M | 31.1M | 690.48K | 438.68K | 1.97M | 8.03M |
Net Cash Flow | 14.74M | -17.83M | -2.34M | 22.26M | 2.11M | -14.44M | -11.99M | 11.68M | -15.78M | -54.75M | -30.37M | -20.55M | 190.6M | 45.67M | -26.68M | 154.13M | -11.31M | -1.77M | -28.15M | -26.6M | -23.44M | -19.22M |
Free Cash Flow | -32.83M | -20.82M | -18.72M | 988K | -32.44M | -43.71M | -26.23M | -18.48M | -30.16M | -53.57M | -30.37M | -53.92M | -55.48M | -5.89M | -27.74M | -22.82M | -33.78M | -32.87M | -28.53M | -27.03M | -25.41M | -27.25M |
Adj. Free Cash Flow | -59.98M | -44.26M | -41.45M | -22.12M | -57.05M | -67.02M | -48.22M | -40.14M | -51.54M | -73.76M | -49.28M | -68.76M | -71.4M | -18.84M | -38.51M | -32.02M | -43.94M | -40.47M | -34.42M | -32.76M | -30.87M | -30.98M |
Maintenance CapEx | -121K | -121K | n/a | n/a | n/a | n/a | n/a | 300K | n/a | -98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -213.74K | -307.41K | -258.68K | -18.88K | -30K |
Growth CapEx | 242K | n/a | -71K | -58K | -13K | -338K | -30K | -150K | -52K | n/a | -7K | -371K | -133K | -71K | -180.86K | -66.06K | -241.46K | n/a | 614.96K | n/a | n/a | n/a |
Owner Earnings | -33.07M | -20.82M | -18.65M | 1.05M | -32.42M | -43.38M | -26.2M | -18.33M | -30.11M | -53.57M | -30.36M | -53.55M | -55.35M | -5.82M | -27.56M | -22.76M | -33.54M | -32.87M | -29.15M | -27.03M | -25.41M | -27.25M |
Add to Watchlist
Select watchlists to add or remove AXSM